Search results

2 results for lithium carbonate

Sorted by Relevance . Sort by Date

Evidence type: Guidance Remove Evidence type: Guidance filter
Evidence type: Policy and Strategy Remove Evidence type: Policy and Strategy filter
Evidence type: Prescribing and Technical Information Remove Evidence type: Prescribing and Technical Information filter
Evidence type: Health Technology Assessments Remove Evidence type: Health Technology Assessments filter
Accredited Remove Accredited filter
Source: Clinical Knowledge Summaries - CKS Remove Source: Clinical Knowledge Summaries - CKS filter
Source: GOV UK Remove Source: GOV UK filter
Source: Public Health England - PHE Remove Source: Public Health England - PHE filter
Source: British National Formulary - BNF Remove Source: British National Formulary - BNF filter
Source: electronic Medicines Compendium - eMC Remove Source: electronic Medicines Compendium - eMC filter

Showing results 1 to 2. View options for downloading these results.

Add this result to my export selection

Bipolar disorder: Lithium

Source:

Clinical Knowledge Summaries - CKS (Remove filter)

01 April 2021

Always prescribe lithium by brand name as preparations vary widely in bioavailability.

Type:

Guidance (Remove filter)
Add this result to my export selection

UK SMI B 40: investigation of specimens for Mycobacterium species (PDF)

Source:

GOV UK (Remove filter)

Source:

Public Health England - PHE (Remove filter)

Published by Public Health England, 02 November 2020

washings should be neutralised by adding approximately 100mg of sodium carbonate to approximately 50mL of the specimen if processing is...

Type:

Policy and Strategy (Remove filter)

Page 1 of 1